About

Curity Pharma SA is a vertically integrated pharmaceutical company specializing in the cultivation, production, and distribution of high-quality medical cannabis products. Based in Greece, the company leverages the region’s ideal climate, advanced cultivation techniques, and strict adherence to EU GMP standards to produce pharmaceutical-grade cannabis for both domestic and international markets. With a focus on innovation, compliance, and patient care, Curity Pharma develops cannabinoid-based therapies that address a wide range of medical conditions. The company is committed to sustainability, employing cutting-edge technologies and eco-friendly practices to minimize its environmental impact. Through strategic partnerships, rigorous research and development, and a patient-centric approach, Curity Pharma SA is shaping the future of medical cannabis, delivering safe, effective, and accessible solutions to improve the quality of life for patients worldwide.

Solution & Product

Curity Pharma provides a comprehensive solution for the medical cannabis market by integrating tech-driven cultivation, production, and distribution under EU GMP standards. The company focuses on ensuring the consistent quality, safety, and efficacy of cannabinoid-based therapies to address a wide range of medical conditions. By leveraging technology, sustainable practices, and rigorous compliance, Curity Pharma ensures reliable access to pharmaceutical-grade medical cannabis for patients and healthcare providers.

Innovation & Scalability

Curity Pharma drives innovation in the medical cannabis industry by combining advanced technologies, sustainable practices, and research-driven approaches to improve patient outcomes and operational efficiency. Precision Cultivation: AI and IoT Integration, use of artificial intelligence and Internet of Things (IoT) sensors to monitor and control environmental factors such as light, temperature, humidity, and CO2 levels in real-time for optimized plant growth. Data-Driven Phenotyping: Leveraging data analytics to identify and cultivate high-performing strains with targeted cannabinoid and terpene profiles. Pharmaceutical-Grade Quality: EU GMP Compliance, strict adherence to pharmaceutical manufacturing standards ensures consistency, safety, and efficacy of all products. Advanced Extraction Techniques: Utilizing cutting-edge methods like CO2 extraction to maximize purity and maintain the integrity of cannabinoids and terpenes. Custom Therapeutics: Development of condition-specific cannabinoid formulations, including precise ratios of THC, CBD, and minor cannabinoids, tailored to patient needs. Sustainability and Efficiency: Renewable energy sources to reduce environmental impact. Patient-Centric Approach: Offering products with consistent dosing and easy-to-use formats for greater accessibility. Providing digital tools for patient and physician support, including dosing calculators and treatment trackers.

Traction & achievements

Curity Pharma SA has achieved significant milestones, establishing itself in the medical cannabis industry. Our progress reflects our commitment to quality, innovation, and patient-focused solutions. Curity Pharma has established itself as a prominent player in the medical cannabis industry, achieving significant milestones across operations, market presence, and innovation. The company has developed a state-of-the-art cultivation facility, fully compliant with EU GMP standards, ensuring the production of pharmaceutical-grade cannabis. In terms of market reach, Curity Pharma has forged strategic partnerships with key distributors in Greece while working towards successfully accessing highly regulated markets such as Germany, the UK, Israel and Australia. With a strong focus on exports, the company is poised to supply bulk medical cannabis materials to international pharmaceutical manufacturers. On the product development front, Curity Pharma is set to launch a diverse range of cannabinoid-based therapies, including tinctures and dried flowers, while advancing patient-focused formats in collaboration with healthcare providers. Additionally, the company is committed to innovation through R&D, aiming to partner with leading institutions to conduct clinical trials and validate the efficacy of cannabinoid-based treatments.

Team & Why Us

Curity Pharma is driven by a multidisciplinary team of industry experts, united by a shared passion for advancing medical cannabis to improve lives. Our team combines deep expertise in cultivation, pharmaceuticals, technology, and business development to deliver exceptional results across every aspect of the company. Curity Pharma fosters a culture of innovation, collaboration, and excellence, with a shared commitment to improving patient outcomes. The team values continuous learning, integrity, and sustainability, creating an environment where every member is empowered to contribute meaningfully. By prioritizing patient-centric solutions and adhering to the highest standards, Curity Pharma ensures that its culture aligns with its mission to advance medical cannabis globally.

Funding Needs

Curity Pharma is well-positioned to capitalize on growth opportunities, with funding playing a critical role in realizing its long-term vision and reinforcing its standing in the medical cannabis sector.